PharmacoBridge, an SE(3)-equivariant diffusion bridge, generates valid 3D drug-like molecules directly from pharmacophore point clouds and outperforms pocket-based baselines in pharmacophore matching and docking affinity on CrossDocked2020.
Learning to Extend Molecular Scaffolds with Structural Motifs
1 Pith paper cite this work. Polarity classification is still indexing.
abstract
Recent advancements in deep learning-based modeling of molecules promise to accelerate in silico drug discovery. A plethora of generative models is available, building molecules either atom-by-atom and bond-by-bond or fragment-by-fragment. However, many drug discovery projects require a fixed scaffold to be present in the generated molecule, and incorporating that constraint has only recently been explored. Here, we propose MoLeR, a graph-based model that naturally supports scaffolds as initial seed of the generative procedure, which is possible because it is not conditioned on the generation history. Our experiments show that MoLeR performs comparably to state-of-the-art methods on unconstrained molecular optimization tasks, and outperforms them on scaffold-based tasks, while being an order of magnitude faster to train and sample from than existing approaches. Furthermore, we show the influence of a number of seemingly minor design choices on the overall performance.
fields
q-bio.BM 1years
2024 1verdicts
CONDITIONAL 1representative citing papers
citing papers explorer
-
Pharmacophore-guided de novo drug design with diffusion bridge
PharmacoBridge, an SE(3)-equivariant diffusion bridge, generates valid 3D drug-like molecules directly from pharmacophore point clouds and outperforms pocket-based baselines in pharmacophore matching and docking affinity on CrossDocked2020.